First-in-Human Study of ALN-SNCA in Adult Participants with Early Parkinson’s Disease (PD)
ALN-SNCA-PD-2482
Phase 1 other active
Quick answer
First-in-Human Study of ALN-SNCA in Adult Participants with Early Parkinson’s Disease (PD) for Parkinson's disease is a Phase 1 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Parkinson's disease
- Phase
- Phase 1
- Modality
- other
- Status
- active